Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Eric Ahlskog

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Mayo Clinic Proceedings|June 9, 2004
Trimethobenzamide in elderly patientsJ Eric Ahlskog
Neurology|October 24, 2007
Beating a dead horse: dopamine and Parkinson diseaseJ Eric Ahlskog
Mayo Clinic Proceedings|October 5, 2020
Common Myths and Misconceptions That Sidetrack Parkinson Disease Treatment, to the Detriment of PatientsJ Eric Ahlskog
Parkinsonism & Related Disorders|February 15, 2024
Parkinson's disease progression is multifaceted: Evidence for the underlying benchmarksJ Eric Ahlskog
Mayo Clinic Proceedings|July 6, 2014
Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfallsJ Eric Ahlskog
JAMA Neurology|January 20, 2016
New and Appropriate Goals for Parkinson Disease Physical TherapyJ Eric Ahlskog
Current Neurology and Neuroscience Reports|August 22, 2003
Parkinson's disease: is the initial treatment established?J Eric Ahlskog
Physiology & Behavior|May 12, 2011
Pathological behaviors provoked by dopamine agonist therapy of Parkinson's diseaseJ Eric Ahlskog
Postgraduate Medicine|December 9, 2017
Treatment of Parkinson's diseaseJ Eric Ahlskog
Neurology|October 10, 2007
I can't get no satisfaction: still no neuroprotection for Parkinson diseaseJ Eric Ahlskog
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Mayo Clinic Proceedings|June 9, 2004
Trimethobenzamide in elderly patientsJ Eric Ahlskog
Neurology|October 24, 2007
Beating a dead horse: dopamine and Parkinson diseaseJ Eric Ahlskog
Mayo Clinic Proceedings|October 5, 2020
Common Myths and Misconceptions That Sidetrack Parkinson Disease Treatment, to the Detriment of PatientsJ Eric Ahlskog
Parkinsonism & Related Disorders|February 15, 2024
Parkinson's disease progression is multifaceted: Evidence for the underlying benchmarksJ Eric Ahlskog
Mayo Clinic Proceedings|July 6, 2014
Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfallsJ Eric Ahlskog
JAMA Neurology|January 20, 2016
New and Appropriate Goals for Parkinson Disease Physical TherapyJ Eric Ahlskog
Current Neurology and Neuroscience Reports|August 22, 2003
Parkinson's disease: is the initial treatment established?J Eric Ahlskog
Physiology & Behavior|May 12, 2011
Pathological behaviors provoked by dopamine agonist therapy of Parkinson's diseaseJ Eric Ahlskog
Postgraduate Medicine|December 9, 2017
Treatment of Parkinson's diseaseJ Eric Ahlskog
Neurology|October 10, 2007
I can't get no satisfaction: still no neuroprotection for Parkinson diseaseJ Eric Ahlskog
Pageof 17